[ad_1]
Investing.com – Selecta Bio reported on Tuesday third quarter that missed analysts’ forecasts and income that fell wanting expectations.
Selecta Bio introduced earnings per share of $-0.050 on income of $20.71M. Analysts polled by Investing.com anticipated EPS of $-0.006 on income of $24.64M.
Selecta Bio shares are down 49% from the start of the 12 months and are buying and selling at $1.640 , down-from-52-week-high.
Selecta Bio follows different main Healthcare sector earnings this month
Selecta Bio’s report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on income of $80.9B, in comparison with forecasts EPS of $5.43 on income of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on income of $23.79B, in comparison with forecast for EPS of $2.52 on income of $23.46B.
Keep up-to-date on the entire upcoming earnings reviews by visiting Investing.com’s earnings calendar
[ad_2]
Source link